Home › Companies › ROYALTY PHARMA PLC › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ROYALTY PHARMA PLC’s Form 8-K, filed June 6, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 6, 2024: 17 items on ROYALTY PHARMA PLC’s Form 8-K, filed June 6, 2024: 17 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ROYALTY PHARMA PLC in the interactive database Compare manager voting policies
These tallies are ROYALTY PHARMA PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Pablo Legorreta | 469,574,048 | 16,360,957 | 91,560 | -- | 24,764,077 | 97% | Passed (calculated) | — |
| Elect Director: Henry Fernandez | 467,493,605 | 18,441,850 | 91,110 | -- | 24,764,077 | 96% | Passed (calculated) | — |
| Elect Director: Bonnie Bassler, Ph.D. | 480,331,728 | 5,609,040 | 85,797 | -- | 24,764,077 | 99% | Passed (calculated) | — |
| Elect Director: Errol De Souza, Ph.D. | 468,014,051 | 17,919,666 | 92,848 | -- | 24,764,077 | 96% | Passed (calculated) | — |
| Elect Director: Catherine Engelbert | 482,164,279 | 3,725,318 | 136,968 | -- | 24,764,077 | 99.2% | Passed (calculated) | — |
| Elect Director: David Hodgson | 474,265,799 | 11,668,945 | 91,821 | -- | 24,764,077 | 98% | Passed (calculated) | — |
| Elect Director: Ted Love, M.D. | 457,219,827 | 28,488,315 | 318,423 | -- | 24,764,077 | 94% | Passed (calculated) | — |
| Elect Director: Gregory Norden | 472,819,630 | 13,114,794 | 92,141 | -- | 24,764,077 | 97% | Passed (calculated) | — |
| 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers | 448,091,225 | 37,716,521 | 218,819 | -- | 24,764,077 | 92% | Passed (calculated) | — |
| 3. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm | 510,538,774 | 175,866 | 76,002 | -- | -- | 99.9% | Passed (calculated) | — |
| 4. To approve receipt of the Company's U.K. statutory accounts together with the Company's U.K. statutory reports, including the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the fiscal year ended Dece | 510,158,489 | 64,644 | 567,509 | -- | -- | 99.9% | Passed (calculated) | — |
| 5. To approve, the Company's U.K. directors' remuneration policy, included in U.K. directors' remuneration report contained in the U.K. Annual Report and Accounts | 446,941,633 | 38,920,774 | 164,158 | -- | 24,764,077 | 92% | Passed (calculated) | — |
| 6. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts | 448,684,306 | 37,116,575 | 225,684 | -- | 24,764,077 | 92% | Passed (calculated) | — |
| 7. To re-appoint Ernst & Young Chartered Accountants as the Company's U.K. statutory auditor under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. annual report and accounts are pre | 510,533,472 | 190,241 | 66,929 | -- | -- | 99.9% | Passed (calculated) | — |
| 8. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor | 485,875,260 | 100,511 | 50,794 | -- | 24,764,077 | 99.9% | Passed (calculated) | — |
| 9. To authorize the Board of Directors to allot shares | 474,984,226 | 10,910,963 | 131,376 | -- | 24,764,077 | 98% | Passed (calculated) | — |
| 10. To authorize the Board of Directors to allot shares without rights of pre-emption | 455,564,249 | 30,278,595 | 183,721 | -- | 24,764,077 | 94% | Passed (calculated) | — |
Source: ROYALTY PHARMA PLC, Form 8-K, filed with the SEC on June 6, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
410 asset managers disclosed a vote on at least one ROYALTY PHARMA PLC item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ROYALTY PHARMA PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 8 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.4% for (June 22, 2023 meeting) ▼ 0.5 pts
Description as filed by funds: Election of Directors: Bonnie Bassler , Ph.D.
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Bonnie Bassler, Ph.D.”): 480,331,728 for, 5,609,040 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,435,773 for, 13,261 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 87.2% for (June 22, 2023 meeting) ▲ 12.0 pts
Description as filed by funds: Election of Directors: Catherine Engelbert
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Catherine Engelbert”): 482,164,279 for, 3,725,318 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,015,178 for, 385,403 against, 93,799 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 561,708 | 302,978 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.5% for (June 22, 2023 meeting) ▲ 0.1 pts
Description as filed by funds: Election of Directors: David Hodgson
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: David Hodgson”): 474,265,799 for, 11,668,945 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,050,633 for, 398,401 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 561,708 | 302,978 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 92.4% for (June 22, 2023 meeting) ▲ 3.9 pts
Description as filed by funds: Election of Directors: Errol De Souza, Ph.D.
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Errol De Souza, Ph.D.”): 468,014,051 for, 17,919,666 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 118,778,319 for, 2,670,715 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,773,729 | 0 | 0 | Against |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 950,000 | 47,944 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 31,485 | 391,821 | 0 | 0 | Mixed |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 83.2% for (June 22, 2023 meeting) ▲ 14.1 pts
Description as filed by funds: Election of Directors: Gregory Norden
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Gregory Norden”): 472,819,630 for, 13,114,794 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 120,644,730 for, 804,304 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 561,708 | 302,978 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 0 | 379,450 | 0 | 0 | Against |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 85.3% for (June 22, 2023 meeting) ▲ 10.9 pts
Description as filed by funds: ELECTION OF DIRECTORS: Henry Fernandez
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Henry Fernandez”): 467,493,605 for, 18,441,850 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 118,243,354 for, 3,205,680 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,773,729 | 0 | 0 | Against |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 950,000 | 47,944 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 561,708 | 302,978 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 31,485 | 391,821 | 0 | 0 | Mixed |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 98.1% for (June 22, 2023 meeting) ▼ 1.5 pts
Description as filed by funds: Election of Directors: Pablo Legorreta
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Pablo Legorreta”): 469,574,048 for, 16,360,957 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,388,771 for, 263 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 695,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 98.4% for (June 22, 2023 meeting) ▼ 4.2 pts
Description as filed by funds: Election of Directors: Ted Love , M.D.
ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Ted Love, M.D.”): 457,219,827 for, 28,488,315 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 119,317,839 for, 2,071,195 against, 45,346 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,535,322 | 5,737 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 1,098,573 | 0 | 0 | Against |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 695,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 0 | 534,568 | 0 | 0 | Against |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Authorize the Board to allot shares without rights of pre- emption (special resolution).
ROYALTY PHARMA PLC’s own tally for this item (“10. To authorize the Board of Directors to allot shares without rights of pre-emption”): 455,564,249 for, 30,278,595 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 98 asset managers below reported 119,525,855 for, 1,965,158 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 36,727,871 | 1,411,683 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 98 asset managers. All 98 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
The 98 asset managers below reported 121,449,478 for, 41,535 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 98 asset managers. All 98 are in the interactive database (link above).
Combines 12 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 94.5% for (June 22, 2023 meeting) ▼ 2.3 pts
Description as filed by funds: A non-binding advisory vote to approve executive compensation.
ROYALTY PHARMA PLC’s own tally for this item (“2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers”): 448,091,225 for, 37,716,521 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 0 | 7,017,976 | 0 | 0 | Against |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 4,785,936 | 0 | 0 | Against |
| Transamerica | 2,882,812 | 8,007 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,253 | 1 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 950,000 | 47,944 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 302,978 | 561,708 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 695,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 31,485 | 391,821 | 0 | 0 | Mixed |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Fund voting reports, all 98 managers: 107,471,883 for, 14,093,606 against, 18,537 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Morgan Stanley | 35,191,783 | 0 | 0 | 0 | For |
| Fidelity | 31,225,453 | 0 | 0 | 0 | For |
| BlackRock | 14,412,765 | 3,847 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 11,543,720 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10,816,931 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 0 | 8,383,000 | 0 | 0 | Against |
| State Street | 7,447,990 | 0 | 0 | 0 | For |
| JPMorgan | 231 | 6,967,823 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 6,552,228 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 4,199,306 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,592,717 | 61,873 | 0 | 0 | For |
| Northern Trust | 2,751,697 | 0 | 0 | 0 | For |
| John Hancock | 2,652,689 | 0 | 0 | 0 | For |
| Amundi | 267,860 | 1,920,425 | 0 | 0 | Mixed |
| GENERAL ATLANTIC, L.P. | 2,055,039 | 0 | 0 | 0 | For |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0 | 2,014,933 | 0 | 0 | Against |
| NEW SOUTH CAPITAL MANAGEMENT INC | 1,922,447 | 0 | 0 | 0 | For |
| HOMESTEAD ADVISERS CORP | 1,892,540 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 0 | 1,884,988 | 0 | 0 | Against |
| Janus Henderson | 1,882,289 | 0 | 0 | 0 | For |
| Charles Schwab | 1,841,789 | 0 | 0 | 0 | For |
| London LGPS CIV Ltd | 1,820,182 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 1,804,585 | 0 | 0 | Against |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,632,947 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 1,473,940 | 0 | 0 | Against |
Institutional-manager reports, all 338 managers: 173,455,967 for, 35,447,038 against, 39,884 abstained, 2,027 not voted, 163 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containing the directors' remuneration policy) for the fiscal year ended December 31, 2023
ROYALTY PHARMA PLC’s own tally for this item (“6. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts”): 448,684,306 for, 37,116,575 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 0 | 7,017,976 | 0 | 0 | Against |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 4,785,936 | 0 | 0 | Against |
| Transamerica | 2,882,812 | 8,007 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,253 | 1 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 950,000 | 47,944 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 302,978 | 561,708 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 31,485 | 391,821 | 0 | 0 | Mixed |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Fund voting reports, all 96 managers: 107,894,808 for, 13,579,462 against, 16,248 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO LTD | 4,199,306 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,592,717 | 61,873 | 0 | 0 | For |
| Northern Trust | 2,751,697 | 0 | 0 | 0 | For |
| NEW SOUTH CAPITAL MANAGEMENT INC | 1,922,447 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 0 | 1,884,988 | 0 | 0 | Against |
| RAYMOND JAMES & ASSOCIATES | 0 | 736,307 | 0 | 0 | Against |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 329,499 | 0 | 0 | 0 | For |
| Portolan Capital Management, LLC | 287,157 | 0 | 0 | 0 | For |
| TORRAY INVESTMENT PARTNERS LLC | 272,299 | 0 | 0 | 0 | For |
| JPMorgan | 231 | 232,678 | 0 | 0 | Against |
| EVERGREEN CAPITAL MANAGEMENT LLC | 229,940 | 0 | 0 | 0 | For |
| Overbrook Management Corp | 0 | 209,268 | 0 | 0 | Against |
| J. Goldman & Co LP | 178,388 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 177,867 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 176,320 | 0 | 0 | 0 | For |
| Treasurer of the State of North Carolina | 0 | 175,879 | 0 | 0 | Against |
| Korea Investment CORP | 173,748 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 110,704 | 205 | 0 | 0 | For |
| Kovitz Investment Group Partners, LLC | 102,383 | 576 | 0 | 0 | For |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 92,452 | 0 | 0 | 0 | For |
| EASTERN BANK | 56,838 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 43,482 | 0 | 0 | Against |
| Aurora Investment Counsel | 0 | 0 | 39,884 | 0 | Abstain |
| Ridgewood Investments LLC | 31,090 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 19,977 | 0 | 0 | 0 | For |
Institutional-manager reports, all 94 managers: 14,813,423 for, 3,430,451 against, 39,884 abstained, 163 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Approve our U.K. directors' remuneration policy.
ROYALTY PHARMA PLC’s own tally for this item (“5. To approve, the Company's U.K. directors' remuneration policy, included in U.K. directors' remuneration report contained in the U.K. Annual Report and Accounts”): 446,941,633 for, 38,920,774 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 104 asset managers below reported 106,225,028 for, 15,359,761 against, 18,537 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 0 | 7,017,976 | 0 | 0 | Against |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 4,785,936 | 0 | 0 | Against |
| Transamerica | 2,882,812 | 8,007 | 0 | 0 | For |
| Charles Schwab | 0 | 1,773,729 | 0 | 0 | Against |
| Brighthouse | 1,578,253 | 1 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 950,000 | 47,944 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 302,978 | 561,708 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 31,485 | 391,821 | 0 | 0 | Mixed |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 104 asset managers. All 104 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor.
ROYALTY PHARMA PLC’s own tally for this item (“8. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor”): 485,875,260 for, 100,511 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 100 asset managers below reported 121,462,845 for, 12,998 against, 18,537 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 100 asset managers. All 100 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 100.0% for (June 22, 2023 meeting) unchanged
Description as filed by funds: Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm.
ROYALTY PHARMA PLC’s own tally for this item (“3. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm”): 510,538,774 for, 175,866 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 100 asset managers below reported 121,612,986 for, 12,998 against, 18,537 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 100 asset managers. All 100 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2023.
ROYALTY PHARMA PLC’s own tally for this item (“4. To approve receipt of the Company's U.K. statutory accounts together with the Company's U.K. statutory reports, including the directors' report, the strategic report, the directors' remuneration report and the auditor”): 510,158,489 for, 64,644 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,624,906 for, 16,248 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders.
ROYALTY PHARMA PLC’s own tally for this item (“7. To re-appoint Ernst & Young Chartered Accountants as the Company's U.K. statutory auditor under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the”): 510,533,472 for, 190,241 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 121,462,845 for, 12,998 against, 18,537 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 38,139,554 | 0 | 0 | 0 | For |
| Fidelity | 33,129,635 | 0 | 0 | 0 | For |
| Morgan Stanley | 11,541,059 | 0 | 0 | 0 | For |
| Putnam | 7,017,976 | 0 | 0 | 0 | For |
| BlackRock | 5,728,038 | 0 | 0 | 0 | For |
| JPMorgan | 4,785,936 | 0 | 0 | 0 | For |
| Transamerica | 2,890,819 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,729 | 0 | 0 | 0 | For |
| Brighthouse | 1,578,254 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,098,573 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 997,944 | 0 | 0 | 0 | For |
| TIAA | 949,883 | 0 | 0 | 0 | For |
| First Trust | 927,223 | 0 | 0 | 0 | For |
| Jackson National | 864,686 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 793,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 755,563 | 0 | 0 | 0 | For |
| Eaton Vance | 689,870 | 0 | 0 | 0 | For |
| State Street | 534,568 | 0 | 0 | 0 | For |
| HOMESTEAD FUNDS INC | 483,484 | 0 | 0 | 0 | For |
| Victory Capital | 454,919 | 0 | 0 | 0 | For |
| Aberdeen | 451,065 | 0 | 0 | 0 | For |
| Principal | 423,306 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 403,327 | 0 | 0 | 0 | For |
| RBB Fund Trust | 379,450 | 0 | 0 | 0 | For |
| AB EQUITY INCOME FUND INC | 366,869 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. All 99 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 448,623,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.50% |
| 2 | Fidelity | 7.38% |
| 3 | Morgan Stanley | 2.57% |
| 4 | Putnam | 1.56% |
| 5 | BlackRock | 1.28% |
| 6 | JPMorgan | 1.07% |
| 7 | Transamerica | 0.64% |
| 8 | Charles Schwab | 0.40% |
| 9 | Brighthouse | 0.35% |
| 10 | Waddell & Reed | 0.24% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Morgan Stanley | 7.84% |
| 2 | Fidelity | 6.96% |
| 3 | BlackRock | 3.21% |
| 4 | VIKING GLOBAL INVESTORS LP | 2.57% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.41% |
| 6 | Swedbank Robur Fonder AB | 1.87% |
| 7 | State Street | 1.66% |
| 8 | JPMorgan | 1.55% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.46% |
| 10 | BAILLIE GIFFORD & CO LTD | 0.94% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Continuing US Investors Partnership | 145,106,931 | 32.34% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| GISEV Trustees Limited | 43,651,170 | 9.73% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Morgan Stanley | 41,159,749 | 9.17% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| FMR LLC | 31,583,926 | 7.04% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| FMR (Fidelity) | 27,986,714 | 6.24% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 26,200,503 | 5.84% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 10,936,538 | 2.44% | Form 13F, quarter ended March 31, 2024 |
| M. Germano Giuliani | 10,322,592 | 2.30% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| State Street | 9,100,148 | 2.03% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 6,548,054 | 1.46% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 448,623,000 shares outstanding, as reported by ROYALTY PHARMA PLC on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ROYALTY PHARMA PLC's shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 410 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 7,337 separate fund positions. Their filings are grouped here into 17 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation. — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ROYALTY PHARMA PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROYALTY PHARMA PLC’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ROYALTY PHARMA PLC proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “ROYALTY PHARMA (RPRX) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/royalty-pharma-plc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.